Any recommendations on AstraZeneca or Alexion?
Alexion is trading at $121 and the takeover is at $175, post approvals.
Alexion will have moved before you have time to buy it
1 Like
Alexion was seriously undervalued before this. Very interesting. I wonder how this will be dealt with by trading 212 @Tony.V would you be able to tell us?
Thanks.
1 Like
Actually I am disappointed at this scenario, future potential growth was far higher then the price of acquisition.
Yeah me too alittle.
For the most part I agree. You’ll be able to get the tail end of the pump IMO.
I’m also interested to know what will happen with this. I own both Astrazeneca and Alexion shares. I was happy to see Alexion shoot up but I don’t whether to just wait or take profit.
Normally the case with M&A: AstraZeneca stock price will dip temporarily before bouncing back and Alexion will go up it might pull back but it will settle higher than the price before M&A.
Is there any argument, evidence, anti-thesis against this? Any input, comment will be very much appreciated